Exploring a Novel Fasudil-Phospholipid Complex Formulated as Liposomal Thermosensitive in situ Gel for Glaucoma

References

• Leite MT, Sakata LM, Medeiros FA. Managing glaucoma in developing countries. Arq Bras Oftalmol. 2011;74(2):83–84. doi:10.1590/s0004-27492011000200001
   PubMed Web of Science ®Google Scholar
• Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121(11):2081–2090. doi:10.1016/j.ophtha.2014.05.013
   PubMed Web of Science ®Google Scholar
• Braunger BM, Fuchshofer R, Tamm ER. The aqueous humor outflow pathways in glaucoma: a unifying concept of disease mechanisms and causative treatment. Eur J Pharm Biopharm. 2015;95(2):173–181. doi:10.1016/j.ejpb.2015.04.029
   PubMed Web of Science ®Google Scholar
• Tanna AP, Johnson M. Rho kinase inhibitors as a novel treatment for glaucoma and ocular hypertension. Ophthalmology. 2018;125(11):1741–1756. doi:10.1016/j.ophtha.2018.04.040
   PubMed Web of Science ®Google Scholar
• Pattabiraman PP, Toris CB. The exit strategy: pharmacological modulation of extracellular matrix production and deposition for better aqueous humor drainage. Eur J Pharmacol. 2016;787:32–42. doi:10.1016/j.ejphar.2016.04.048
   PubMed Web of Science ®Google Scholar
• Mietzner R, Breunig M. Causative glaucoma treatment: promising targets and delivery systems. Drug Discov Today. 2019;24(8):1606–1613. doi:10.1016/j.drudis.2019.03.017
   PubMed Web of Science ®Google Scholar
• Garnock-Jones KP. Ripasudil: first global approval. Drugs. 2014;74(18):2211–2215. doi:10.1007/s40265-014-0333-2
   PubMed Web of Science ®Google Scholar
• Hoy SM. Netarsudil ophthalmic solution 0.02%: first global approval. Drugs. 2018;78(3):389–396. doi:10.1007/s40265-018-0877-7
   PubMed Web of Science ®Google Scholar
• Honjo M, Tanihara H. Impact of the clinical use of ROCK inhibitor on the pathogenesis and treatment of glaucoma. Jpn J Ophthalmol. 2018;62(2):109–126. doi:10.1007/s10384-018-0566-9
   PubMed Web of Science ®Google Scholar
• Wang SK, Chang RT. An emerging treatment option for glaucoma: rho kinase inhibitors. Clin Ophthalmol. 2014;8:883–890. doi:10.2147/OPTH.S41000
   PubMedGoogle Scholar
• Pakravan M, Naderi Beni A, Ghahari E, et al. The ocular hypotensive efficacy of topical fasudil, a Rho-associated protein kinase inhibitor, in patients with end-stage glaucoma. Am J Ther. 2016;24:1.
   Web of Science ®Google Scholar
• Tetko IV, Gasteiger J, Todeschini R, et al. Virtual computational chemistry laboratory–design and description. J Comput Aided Mol Des. 2005;19(6):453–463. doi:10.1007/s10822-005-8694-y
   PubMed Web of Science ®Google Scholar
• Qin X, Yang Y, Fan TT, Gong T, Zhang XN, Huang Y. Preparation, characterization and in vivo evaluation of bergenin-phospholipid complex. Acta Pharmacol Sin. 2010;31(1):127–136. doi:10.1038/aps.2009.171
   PubMed Web of Science ®Google Scholar
• Ding D, Sun B, Cui W, et al. Integration of phospholipid-drug complex into self-nanoemulsifying drug delivery system to facilitate oral delivery of paclitaxel. Asian J Pharmaceut Sci. 2019;14(5):552–558. doi:10.1016/j.ajps.2018.10.003
   PubMed Web of Science ®Google Scholar
• Ghate D, Edelhauser HF. Barriers to glaucoma drug delivery. J Glaucoma. 2008;17(2):147–156. doi:10.1097/IJG.0b013e31814b990d
   PubMed Web of Science ®Google Scholar
• Bachu RD, Chowdhury P, Al-Saedi ZHF, Karla PK, Boddu SHS. Ocular drug delivery barriers-role of nanocarriers in the treatment of anterior segment ocular diseases. Pharmaceutics. 2018;10(1):28. doi:10.3390/pharmaceutics10010028
   PubMed Web of Science ®Google Scholar
• Shafaa MW, Sabra NM, Fouad RA. The extended ocular hypotensive effect of positive liposomal cholesterol bound timolol maleate in glaucomatous rabbits. Biopharm Drug Dispos. 2011;32(9):507–517. doi:10.1002/bdd.778
   PubMed Web of Science ®Google Scholar
• Monem AS, Ali FM, Ismail MW. Prolonged effect of liposomes encapsulating pilocarpine HCl in normal and glaucomatous rabbits. Int J Pharm. 2000;198(1):29–38. doi:10.1016/s0378-5173(99)00348-8
   PubMed Web of Science ®Google Scholar
• Lombardo D, Calandra P, Barreca D, Magazù S, Kiselev MA. Soft interaction in liposome nanocarriers for therapeutic drug delivery. Nanomaterials. 2016;6(7):125. doi:10.3390/nano6070125
   Web of Science ®Google Scholar
• Fabiano A, Bizzarri R, Zambito Y. Thermosensitive hydrogel based on chitosan and its derivatives containing medicated nanoparticles for transcorneal administration of 5-fluorouracil. Int J Nanomedicine. 2017;12:633–643. doi:10.2147/ijn.s121642
   PubMed Web of Science ®Google Scholar
• Soliman KA, Ullah K, Shah A, Jones DS, Singh TRR. Poloxamer-based in situ gelling thermoresponsive systems for ocular drug delivery applications. Drug Discov Today. 2019;24(8):1575–1586. doi:10.1016/j.drudis.2019.05.036
   PubMed Web of Science ®Google Scholar
• Patel N, Thakkar V, Metalia V, Baldaniya L, Gandhi T, Gohel M. Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept. Drug Dev Ind Pharm. 2016;42(9):1406–1423. doi:10.3109/03639045.2015.1137306
   PubMed Web of Science ®Google Scholar
• Cao F, Zhang X, Ping Q. New method for ophthalmic delivery of azithromycin by poloxamer/carbopol-based in situ gelling system. Drug Deliv. 2010;17(7):500–507. doi:10.3109/10717544.2010.483255
   PubMed Web of Science ®Google Scholar
• Kurniawansyah IS, Gozali D, Sopyan I, Iqbal M, Subarnas A. Physical study of chloramphenicol in situ gel with base hydroxypropyl methylcellulose and poloxamer 188. J Pharm Bioallied Sci. 2019;11(Suppl4):S547–S550. doi:10.4103/jpbs.JPBS_201_19
   PubMed Web of Science ®Google Scholar
• Hüsch J, Dutagaci B, Glaubitz C, et al. Structural properties of so-called NSAID-phospholipid-complexes. Eur J Pharm Sci. 2011;44(1–2):103–116. doi:10.1016/j.ejps.2011.06.010
   PubMed Web of Science ®Google Scholar
• Kuche K, Bhargavi N, Dora CP, Jain S. Drug-phospholipid complex-A go through strategy for enhanced oral bioavailability. AAPS PharmSciTech. 2019;20(2):43. doi:10.1208/s12249-018-1252-4
   PubMed Web of Science ®Google Scholar
• Domazou AS, Luigi Luisi P. Size distribution of spontaneously formed liposomes by the alcohol injection method. J Liposome Res. 2002;12(3):205–220. doi:10.1081/LPR-120014758
   PubMed Web of Science ®Google Scholar
• Gao D, Tang S, Tong Q. Oleanolic acid liposomes with polyethylene glycol modification: promising antitumor drug delivery. Int J Nanomedicine. 2012;7:3517–3526. doi:10.2147/ijn.s31725
   PubMed Web of Science ®Google Scholar
• Eldesouky LM, El-Moslemany RM, Ramadan AA, Morsi MH, Khalafallah NM. Cyclosporine lipid nanocapsules as thermoresponsive gel for dry eye management: promising corneal mucoadhesion, biodistribution and preclinical efficacy in rabbits. Pharmaceutics. 2021;13(3):360. doi:10.3390/pharmaceutics13030360
   PubMed Web of Science ®Google Scholar
• Morsi N, Ghorab D, Refai H, Teba H. Ketoroloac tromethamine loaded nanodispersion incorporated into thermosensitive in situ gel for prolonged ocular delivery. Int J Pharm. 2016;506(1–2):57–67. doi:10.1016/j.ijpharm.2016.04.021
   PubMed Web of Science ®Google Scholar
• Fathalla MA, Vangala A, Longman M, et al. Poloxamer-based thermoresponsive ketorolac tromethamine in situ gel preparations: design, characterisation, toxicity and transcorneal permeation studies. Eur J Pharmaceut Biopharmaceut. 2017;114:119–134. doi:10.1016/j.ejpb.2017.01.008
   PubMed Web of Science ®Google Scholar
• Alomrani A, Badran M, Harisa GI, et al. The use of chitosan-coated flexible liposomes as a remarkable carrier to enhance the antitumor efficacy of 5-fluorouracil against colorectal cancer. Saudi Pharmaceut J. 2019;27(5):603–611. doi:10.1016/j.jsps.2019.02.008
   PubMed Web of Science ®Google Scholar
• Gupta N, Al-Saikhan FI, Patel B, Rashid J, Ahsan F. Fasudil and SOD packaged in peptide-studded-liposomes: properties, pharmacokinetics and ex-vivo targeting to isolated perfused rat lungs. Int J Pharm. 2015;488(1):33–43. doi:10.1016/j.ijpharm.2015.04.031
   PubMed Web of Science ®Google Scholar
• Tan G, Yu S, Pan H, et al. Bioadhesive chitosan-loaded liposomes: a more efficient and higher permeable ocular delivery platform for timolol maleate. Int J Biol Macromol. 2017;94:355–363. doi:10.1016/j.ijbiomac.2016.10.035
   PubMed Web of Science ®Google Scholar
• Fahmy HM, Saad EAE-MS, Sabra NM, El-Gohary AA, Mohamed FF, Gaber MH. Treatment merits of latanoprost/thymoquinone – encapsulated liposome for glaucomatus rabbits. Int J Pharm. 2018;548(1):597–608. doi:10.1016/j.ijpharm.2018.07.012
   PubMed Web of Science ®Google Scholar
• Tan G, Yu S, Li J, Pan W. Development and characterization of nanostructured lipid carriers based chitosan thermosensitive hydrogel for delivery of dexamethasone. Int J Biol Macromol. 2017;103:941–947. doi:10.1016/j.ijbiomac.2017.05.132
   PubMed Web of Science ®Google Scholar
• Huang W, Zhang N, Hua H, et al. Preparation, pharmacokinetics and pharmacodynamics of ophthalmic thermosensitive in situ hydrogel of betaxolol hydrochloride. Biomed Pharmacother. 2016;83:107–113. doi:10.1016/j.biopha.2016.06.024
   PubMed Web of Science ®Google Scholar
• Lee C-A, Kim B-S, Cho C-W. Quantitative evaluation of mucoadhesive polymers to compare the mucoadhesion. J Pharmaceut Investig. 2016;46(2):189–194. doi:10.1007/s40005-016-0233-4
   Google Scholar
• Pecora TMG, Ragazzo B, Bertin W, et al. Rheological behavior of a new mucoadhesive oral formulation based on Sodium Chondroitin Sulfate, Xyloglucan and Glycerol. J Funct Biomater. 2021;12(2):28. doi:10.3390/jfb12020028
   PubMed Web of Science ®Google Scholar
• Aggarwal D, Garg A, Kaur IP. Development of a topical niosomal preparation of Acetazolamide: preparation and evaluation. J Pharm Pharmacol. 2004;56(12):1509–1517. doi:10.1211/0022357044896
   PubMed Web of Science ®Google Scholar
• Cañadas C, Alvarado H, Calpena AC, et al. In vitro, ex vivo and in vivo characterization of PLGA nanoparticles loading pranoprofen for ocular administration. Int J Pharm. 2016;511(2):719–727. doi:10.1016/j.ijpharm.2016.07.055
   PubMed Web of Science ®Google Scholar
• Kaskoos RA. Investigation of moxifloxacin loaded chitosan-dextran nanoparticles for topical instillation into eye: in-vitro and ex-vivo evaluation. Int J Pharm Investig. 2014;4(4):164–173. doi:10.4103/2230-973X.143114
   PubMedGoogle Scholar
• Gupta H, Aqil M, Khar RK, Ali A, Bhatnagar A, Mittal G. Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery. Nanomedicine. 2010;6(2):324–333. doi:10.1016/j.nano.2009.10.004
   PubMed Web of Science ®Google Scholar
• McKenzie B, Kay G, Matthews KH, Knott RM, Cairns D. The hen’s egg chorioallantoic membrane (HET-CAM) test to predict the ophthalmic irritation potential of a cysteamine-containing gel: quantification using Photoshop® and ImageJ. Int J Pharm. 2015;490(1–2):1–8. doi:10.1016/j.ijpharm.2015.05.023
   PubMed Web of Science ®Google Scholar
• Shokry M, Hathout RM, Mansour S. Exploring gelatin nanoparticles as novel nanocarriers for Timolol Maleate: augmented in-vivo efficacy and safe histological profile. Int J Pharm. 2018;545(1):229–239. doi:10.1016/j.ijpharm.2018.04.059
   PubMed Web of Science ®Google Scholar
• Morsi N, Ibrahim M, Refai H, El Sorogy H. Nanoemulsion-based electrolyte triggered in situ gel for ocular delivery of Acetazolamide. Eur J Pharmaceut Sci. 2017;104:302–314. doi:10.1016/j.ejps.2017.04.013
   PubMed Web of Science ®Google Scholar
• Ebada HMK, Nasra MMA, Elnaggar YSR, Abdallah OY. Novel rhein–phospholipid complex targeting skin diseases: development, in vitro, ex vivo, and in vivo studies. Drug Deliv Transl Res. 2021;11(3):1107–1118. doi:10.1007/s13346-020-00833-1
   PubMed Web of Science ®Google Scholar
• Pathak S, Mishra R, Kumar S, Prakash GS, Parthasarthy R. Effect of cholesterol concentration on size of liposome. IOSR J Pharm Biol Sci. 2012;1(1):50–53. doi:10.9790/3008-0115053
   Google Scholar
• Jaafar-Maalej C, Diab R, Andrieu V, Elaissari A, Fessi H. Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation. J Liposome Res. 2010;20(3):228–243. doi:10.3109/08982100903347923
   PubMed Web of Science ®Google Scholar
• Vázquez-González ML, Bernad R, Calpena AC, Domènech O, Montero MT, Hernández-Borrell J. Improving ex vivo skin permeation of non-steroidal anti-inflammatory drugs: enhancing extemporaneous transformation of liposomes into planar lipid bilayers. Int J Pharm. 2014;461(1):427–436. doi:10.1016/j.ijpharm.2013.12.009
   PubMed Web of Science ®Google Scholar
• Yu S, Wang Q-M, Wang X, et al. Liposome incorporated ion sensitive in situ gels for ophthalmic delivery of timolol maleate. Int J Pharm. 2015;480(1–2):128–136. doi:10.1016/j.ijpharm.2015.01.032
   PubMed Web of Science ®Google Scholar
• Mura P, Mennini N, Nativi C, Richichi B. In situ mucoadhesive-thermosensitive liposomal gel as a novel vehicle for nasal extended delivery of opiorphin. Eur J Pharm Biopharm. 2018;122:54–61. doi:10.1016/j.ejpb.2017.10.008
   PubMed Web of Science ®Google Scholar
• Da Silva JB, Cook MT, Bruschi ML. Thermoresponsive systems composed of poloxamer 407 and HPMC or NaCMC: mechanical, rheological and sol-gel transition analysis. Carbohydr Polym. 2020;240:116268. doi:10.1016/j.carbpol.2020.116268
   PubMed Web of Science ®Google Scholar
• Venkatesh DMP, Kamlesh L, Kumar P. Development and evaluation of chitosan based thermosensitive in situ gels of pilocarpine. Int J Pharm Pharmaceut Sci. 2013;5:164–169.
   Google Scholar
• Ricci EJ, Lunardi LO, Nanclares DM, Marchetti JM. Sustained release of lidocaine from Poloxamer 407 gels. Int J Pharm. 2005;288(2):235–244. doi:10.1016/j.ijpharm.2004.09.028
   PubMed Web of Science ®Google Scholar
• Baranowski P, Karolewicz B, Gajda M, Pluta J. Ophthalmic drug dosage forms: characterisation and research methods. Sci World J. 2014;2014:861904. doi:10.1155/2014/861904
   Web of Science ®Google Scholar
• Zhang B, Chen J, Lu Y, Qi J, Wu W. Liposomes interiorly thickened with thermosensitive nanogels as novel drug delivery systems. Int J Pharm. 2013;455(1–2):276–284. doi:10.1016/j.ijpharm.2013.07.020
   PubMed Web of Science ®Google Scholar
• El-Kamel AH. In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate. Int J Pharm. 2002;241(1):47–55. doi:10.1016/s0378-5173(02)00234-x
   PubMed Web of Science ®Google Scholar
• Zhang ZJ, Osmałek T. Deformable liposomal hydrogel for dermal and transdermal delivery of meloxicam. Int J Nanomedicine. 2020;15:9319–9335. doi:10.2147/ijn.s274954
   PubMed Web of Science ®Google Scholar
• Leriche G, Cifelli J, Sibucao K, et al. Characterization of drug encapsulation and retention in archaea-inspired tetraether liposomes. Org Biomol Chem. 2017;15(10):2157–2162. doi:10.1039/C6OB02832B
   PubMed Web of Science ®Google Scholar
• Mehanna MM, El-Kader NA, Samaha MW. Liposomes as potential carriers for ketorolac ophthalmic delivery: formulation and stability issues. Braz J Pharmaceut Sci. 2017;53(2). doi:10.1590/s2175-97902017000216127
   Web of Science ®Google Scholar
• Paarakh MP, Jose PA, Setty C, Christoper GVP. Release kinetics – concepts and applications. Int J Pharm Res Tech. 2018;8:12–20.
   Google Scholar
• Nie S, Hsiao WL, Pan W, Yang Z. Thermoreversible Pluronic F127-based hydrogel containing liposomes for the controlled delivery of paclitaxel: in vitro drug release, cell cytotoxicity, and uptake studies. Int J Nanomedicine. 2011;6:151–166. doi:10.2147/ijn.s15057
   PubMed Web of Science ®Google Scholar
• Silva MM, Calado R, Marto J, Bettencourt A, Almeida AJ, Gonçalves LMD. Chitosan nanoparticles as a mucoadhesive drug delivery system for ocular administration. Mar Drugs. 2017;15(12). doi:10.3390/md15120370
   Web of Science ®Google Scholar
• Li H, Liu Y, Zhang Y, et al. Liposomes as a novel ocular delivery system for brinzolamide: in vitro and in vivo studies. AAPS PharmSciTech. 2016;17(3):710–717. doi:10.1208/s12249-015-0382-1
   PubMed Web of Science ®Google Scholar
• Spielmann H, Castle J, Gomez M. In Vitro Methods in Pharmaceutical Research. San Diego, CA: Academic Press; 1997.
   Google Scholar
• Worakul N, Robinson JR. Ocular pharmacokinetics/pharmacodynamics. Eur J Pharmaceut Biopharmaceut. 1997;44(1):71–83. doi:10.1016/S0939-6411(97)00064-7
   Web of Science ®Google Scholar
• Mohsen AM, Salama A, Kassem AA. Development of Acetazolamide loaded bilosomes for improved ocular delivery: preparation, characterization and in vivo evaluation. J Drug Deliv Sci Technol. 2020;59:101910. doi:10.1016/j.jddst.2020.101910
   Web of Science ®Google Scholar
• He W, Guo X, Feng M, Mao N. In vitro and in vivo studies on ocular vitamin A palmitate cationic liposomal in situ gels. Int J Pharm. 2013;458(2):305–314. doi:10.1016/j.ijpharm.2013.10.033
   PubMed Web of Science ®Google Scholar